The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm.
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management.
Prognostic value, clinical relevance, and methodological gaps of tumor burden in neuroendocrine tumors (NETs): A systematic review of phase III randomized trials of medical therapies.
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective database.
<p class="MDPI12title"><span lang="EN-US" style="mso-bidi-font-size: 18.0pt;">In vivo and In Vitro Efficacy of Statin Therapy in Combination with Somatostatin Analogues in Advanced Bronchopulmonary Neuroendocrine Tumors
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy.
Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysis.
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study.
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).
Incidental Gastric Neuroendocrine Tumor on Histology: What Should the Gastroenterologist Do Next?
Statins Support the Antitumor Activity of Somatostatin Analogues in Advanced Bronchopulmonary Neuroendocrine Tumors: A Clinical and In Vitro Study
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries
Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries.
The importance of education and training in neuroendocrine neoplasms: challenges and opportunities for multidisciplinary management.
The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms - A systematic review.
Rethinking chromogranin A: unveiling gastrointestinal factors beyond neuroendocrine neoplasms-a narrative review.
Controversies in NEN: An ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms.
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review.
Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients?
Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids.
Glucagonoma and Glucagonoma Syndrome: An Updated Review.
Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study.
Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms.
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs.
A Randomized clinical trial evaluating the impact on survival and quality of life of <sup>177</sup>Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors.
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
Rectal neuroendocrine tumors: Can we predict their behavior?
A systematic review on endoscopic ultrasound in gastric neuroendocrine neoplasms: guidelines outpacing evidence.